Eiry Roberts

Companies

• Bausch HealthBoard member May 20, 2026 to now¹
• Amicus TherapeuticsBoard member Jun 14, 2021 to now²
• Neurocrine BiosciencesChief Medical Officer Jan 10, 2018 to Feb 14, 2025³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX35,640 shares⁴$4.9M at $136.95Feb 14, 2025
• Bausch Health BHC45,871 shares⁵$289.2K at $6.30May 22, 2026
• Amicus Therapeutics FOLD0 shares⁶Apr 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 22, 2026Granted 45,871 shares of Bausch Health⁵
• Apr 27, 2026Returned to company 76,275 shares at $14.50 of Amicus Therapeutics⁶
• Jun 5, 2025Granted 20,414 shares of Amicus Therapeutics⁷
• Feb 14, 2025Sold 500 shares at $115.04 of Neurocrine Biosciences⁴
• Feb 13, 2025Exercised options 1,372 shares of Neurocrine Biosciences⁴
• Feb 13, 2025Sold 604 shares at $116.74 of Neurocrine Biosciences⁴
• Feb 13, 2025Exercised options 1,120 shares of Neurocrine Biosciences⁴
• Feb 13, 2025Sold 1,114 shares at $116.90 of Neurocrine Biosciences⁴
• Feb 13, 2025Exercised options 2,113 shares of Neurocrine Biosciences⁴
• Feb 10, 2025Sold 980 shares at $118.22 of Neurocrine Biosciences⁸
• Feb 8, 2025Exercised options 1,860 shares of Neurocrine Biosciences⁸
• Jan 31, 2025Sold 1,457 shares at $152.80 of Neurocrine Biosciences⁹
• Jan 31, 2025Exercised options 2,769 shares of Neurocrine Biosciences⁹
• Nov 8, 2024Exercised options 1 shares at $79.02 of Neurocrine Biosciences¹⁰
• Nov 8, 2024Exercised options 971 shares at $102.90 of Neurocrine Biosciences¹⁰
• Nov 8, 2024Exercised options 1,233 shares at $81.05 of Neurocrine Biosciences¹⁰
• Nov 8, 2024Exercised options 5,140 shares at $77.81 of Neurocrine Biosciences¹⁰
• Jun 6, 2024Granted 11,847 shares of Amicus Therapeutics¹¹
• Feb 13, 2024Sold 1,114 shares at $132.96 of Neurocrine Biosciences¹²
• Feb 8, 2024Sold 980 shares at $134.21 of Neurocrine Biosciences¹³
• Feb 6, 2024Sold 1,121 shares at $142.24 of Neurocrine Biosciences¹³
• Jan 31, 2024Sold 1,457 shares at $140.79 of Neurocrine Biosciences¹⁴
• Dec 22, 2023Sold 10,000 shares at $126.74 of Neurocrine Biosciences¹⁵
• Dec 12, 2023Sold 6,947 shares at $120.31 of Neurocrine Biosciences¹⁶
• Dec 12, 2023Exercised options 6,947 shares at $81.05 of Neurocrine Biosciences¹⁶